Basudeb Maji

Switchable Cas9

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs

A scoutRNA Is Required for Some Type V CRISPR-Cas Systems

CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification

Temperature-Responsive Competitive Inhibition of CRISPR-Cas9

Controlling and enhancing CRISPR systems

Pt(ii) squares as selective and effective human telomeric G-quadruplex binders and potential cancer therapeutics

Genome editing by natural and engineered CRISPR-associated nucleases

Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors

Bridge helix arginines play a critical role in Cas9 sensitivity to mismatches

PROTAC targeted protein degraders: the past is prologue

Broad-spectrum enzymatic inhibition of CRISPR-Cas12a

Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras

Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation

Massively parallel kinetic profiling of natural and engineered CRISPR nucleases

Systematic discovery of natural CRISPR-Cas12a inhibitors

The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials

Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling

CRISPR-Cas guides the future of genetic engineering

CRISPR-Cas in Streptococcus pyogenes

Metal–Organic Frameworks and Self-Assembled Supramolecular Coordination Complexes: Comparing and Contrasting the Design, Synthesis, and Functionality of Metal–Organic Materials

Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis

Understanding the Molecular Mechanisms of the CRISPR Toolbox Using Single Molecule Approaches

Protein Inhibitors of CRISPR-Cas9

Multidimensional chemical control of CRISPR–Cas9

A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9

Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA

A Singular System with Precise Dosing and Spatiotemporal Control of CRISPR‐Cas9

Precision Control of CRISPR-Cas9 Using Small Molecules and Light

Dimeric 1,3-Phenylene-bis(piperazinyl benzimidazole)s: Synthesis and Structure–Activity Investigations on their Binding with Human Telomeric G-Quadruplex DNA and Telomerase Inhibition Properties